Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose

Cell Proliferation

Volumn 31, Issue 2, 1998, Pages 71-92

  Eto, I ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AGAROSE; CALCITRIOL; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; DEXAMETHASONE; DNA; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL SUSPENSION; CONTROLLED STUDY; DNA SYNTHESIS; EPIDERMIS CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; TUMOR PROMOTION;

ANIMALIA;

EID: 0031689595     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1998.00112.x     Document Type: Article

References (73)

1. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589.
2. Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12, 2315.
3. ARGYRIS TS. (1981) Ribosomal RNA synthesis throughout epidermal hyperplastic growth induced by abrasion or treatment with 12-O-tetradecanoyl-phorbol-13-acetate. J. Invest. Dermatol. 76, 388.
4. ARGYRIS TS. (1983) Ribosomal RNA synthesis and growth in mouse epidermis following initiation with dimethylbenzanthracene and promotion with 12-O-tetradecanoyl-phorbol-13-acetate. J. Invest. Dermatol. 80, 73.
5. ASTRUC ME, CHABRET C, BALI P, GAGNE D, PONS M. (1995) Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor. Endocrinology 136, 824.
6. BAIRD WM, SEDGWICK JA, BOUTWELL RK. (1971) Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. Cancer Res. 31, 1434.
7. BEN-ARI ET, BERNSTEIN LR, COLBURN NH. (1992) Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Mol. Carcinogen. 5, 62.
8. BERNSTEIN LR, COLBURN NH. (1989) AP-1/jun function is differentially induced in promotion sensitive and resistant JB6 cells. Science 244, 566.
9. BERNSTEIN LR, BEN-ARI ET, SIMEK SL, COLBURN NH. (1991) Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells. Environ. Health Perspect. 93, 111.
10. BERNSTEIN LR, BRAVO R, COLBURN NH. (1992) 12-O-Tetradecanoylphorbol-13-acetate-induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells. Mol. Carcinogen. 6, 221.
11. BOTZ, J, ZERFASS-THOME K, SPITKOVSKY D. et al. (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16, 3401.
12. CHANG PL, PRINCE, CW. (1993) 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate in mouse JB6 epidermal cells. Cancer Res. 53, 2217.
13. CHAO Y, PELLEGRINI M. (1993) In vitro transcription of Drosophila rRNA genes shows stimulation by a phorbol ester and serum. Mol. Cell. Biol. 13, 934.
14. CHOMCZYNSKI P, MACKEY K. (1995) Modification of the TRI Reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. BioTechnique 19, 942.
15. 3. Biochem. J. 316, 361.
16. COLBURN NH, BRUEGGE WFV, BATES JR. et al. (1978) Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38, 624.
17. COLBURN NH, FORMER BF, NELSON KA, YUSPA SH. (1979) Tumour promoters induce anchorage independence irreversibly. Nature 281, 589.
18. COLBURN NH, KOEHLER BA, NELSON KJ. (1980) A cell culture assay for tumor-promoter-dependent progression toward neoplastic phenotype: detection of tumor promoters and promotion inhibitors. Teratogen. Carcinogen. Mutagen. 1, 87.
19. COLBURN NH, OZANNE S, LICHTI U. et al. (1981) Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines. Ann. NY Acad. Sci. 359, 251.
20. DE YOUNG LM, ARGYRIS TS, GORDON GB. (1977) Epidermal ribosome accumulation during two-stage skin tumorigenesis. Cancer Res. 37, 388.
21. DION LD, GINHART TD, COLBURN NH. (1988) Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence. Cancer Res. 48, 7126.
22. DONG Z, CMARIK JL, WENDEL EJ, COLBURN NH. (1994a) Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 15, 1001.
23. DONG Z, BIRRER MJ, WATTS RG, MATRISIAN LM, COLBURN NH. (1994b) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA 91, 609.
24. DONG Z, LAVROVSKY V, COLBURN NH. (1995) Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 16, 749.
25. DUMONT JA, BITONTI AJ, WALLACE CD, BAUMANN RJ, CASHMAN EA, CROSS-DOERSEN DE. (1996) Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ. 7, 351.
26. FANG, F, OREND G, WATANABE N, HUNTER T, RUOSLAHTI E. (1996) Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271, 499.
27. GAUB MP, BELLARD M, SCHEUER I, CHAMBON P, SASSONE-CORSI P. (1990) Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63, 1267.
28. GENG Y, EATON EN, PICON M. et al. (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12, 1173.
29. GIRARD F, STRAUSFELD U, FERNANDEZ A, LAMB NJ. (1991) Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169.
30. GNIADECKI R. (1996) Activation of Raf-mitogen-activated protein kinase signaling pathway by 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J. Investig. Dermatol. 106, 1212.
31. GUADAGNO TM, ASSOIAN RK. (1991) G1/S control of anchorage-independent growth in the fibroblast cell cycle. J. Cell Biol. 115, 1419.
32. GUADAGNO TM, OUTSUBO M, ROBERTS JM, ASSOIAN RK. (1993) A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262, 1572.
33. HAN EKH, GUADAGNO TM, DALTON SL, ASSOIAN RK. (1993) A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-β1 control G1/S transit specifically. J. Cell Biol. 122, 461.
34. HANNAN RD, ROTHBLUM LI. (1995) Regulation of ribosomal DNA transcription during neonatal cardiomyocyte hypertrophy. Cardiovascular Res. 30, 501.
35. HERBER B, TRUSS M, BEATO M, MÜLLER R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogens 9, 1295.
36. JONAT C, RAHMSDORF HJ, PARK KK et al. (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189.
37. KIM S, BROWN PH, BIRRER MJ. (1996) The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor. Oncogene 12, 1043.
38. LABAER J, GARRETT MD, STEVENSON LF. et al. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Develop. 11, 847.
39. LAVROVSKY V, DONG Z, MA WY, COLBURN N. (1996) Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells. In Vitro Cell. Develop. Biol. Animal 32, 234.
40. LI JJ, DONG Z, DAWSON MI, COLBORN NH. (1996) Inhibition of tumor promoter induced transformation by retinoids that transrepress AP-1 without transactivating RARE. Cancer Res. 56, 483.
41. LI JJ, WESTERGAARD C, GHOSH P, COLBURN NH. (1997) Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 57, 3569.
42. LIU M, LEE MH, COHEN M, BOMMAKANTI M, FREEDMAN LP. (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cells line U937. Genes Development 10, 142.
43. MCGARRITY GJ, STEINER T, VANAMAN V. (1983) Detection of mycoplasmal infection of cell cultures by DNA fluorochrome staining. In: Tully JG, Razin S, eds. Methods in Mycoplasmology, 2nd Vol. New York: Academic Press, 155.
44. MCKENZIE KE, ARMSTRONG BA, CHEN Y, NAGARAJAN M, ALDAZ CM, SUKUMAR S. (1997) Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors. Mol. Carcinogenesis 20, 194.
45. MORO A, ZERFASS K, JOSWIG S, JANSEN-DUERR P. (1997) Effect of cyclins and Cdks on the cyclin B1 promoter. Biochem. Mol. Biol. Int. 41, 919.
46. PAECH K, WEBB P, KUIPER GGJM. et al. (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277, 1508.
47. PAGANO M, PEPPERKOK R, VERDE F, ANSORGE W, DRAETTA G. (1992) Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961.
48. PHILIPS A, CHALBOS D, ROCHEFORT H. (1993) Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem. 268, 14 103.
49. PLANAS-SILVA M, WEINBERG RA. (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17, 4059.
50. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-cdk2. J. Biol. Chem. 272, 10 882.
51. ROUSSEL MF, THEODORAS AM, PAGANO M, SHERR CJ. (1995) Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92, 6837.
52. SAVOURET JF, RAUCH M, REDEUILH G. et al. (1994) Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J. Biol. Chem. 269, 28 955.
53. SCHULZE A, ZERFASS K, SPITKOVSKY D et al. (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92, 11 264.
54. SCHULZE A, ZERFASS-THOME K, BERGES J, MIDDENDORP S, JANSEN-DURR P, HENGLEIN B. (1996) Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16, 4632.
55. SHERR CJ. (1996) Cancer cell cycles. Science 274, 1672.
56. SIRICA AE. (1996) Multistage carcinogenesis. In: Sirica AE, ed. Cellular and Molecular Pathogenesis. Philadelphia: Lippincott-Raven Publishers, 283.
57. SOPRANO DR, CHEN LX, WU S, DONIGAN AM, BORGHACI RC, SOPRANO KJ. (1996) Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition. Oncogene 12, 577.
58. SPITKOVSKY D, SCHULZE A, BOYE B, JANSEN-DURR P. (1997) Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Different. 8, 699.
59. STRICKLAND J, SUN Y, DONG Z, COLBURN NH. (1997) Grafting assay distinguishes promotion sensitive from promotion resistant JB6 cells. Carcinogenesis 18, 1135.
60. STRUGNELL SA, DELUCA HF. (1997) The vitamin D receptor - structure and transcriptional activation. Proc. Soc. Exp. Biol. Med. 215, 223.
61. SUKUMAR S, CARNEY WP, BARBACID M. (1988) Independent molecular pathways in initiation and loss of hormone responsiveness of breast cancer. Science 240, 524.
62. UHT RM, ANDERSON CM, WEBB P, KUSHNER PJ. (1997) Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 138, 2900.
63. UMAYAHARA Y, KAWAMORI R, WATADA H. et al. (1994) Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269, 16 433.
64. WANG KKW, POSNER A, HAJIMOHAMMADREZA I. (1996) Total protein extraction from cultured cells for use in electrophoresis and Western blotting. BioTechnique 20, 662.
65. WATANABE G, HOWE A, LEE RJ et al. (1996) Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93, 12 861.
66. WATTS RG, BEN-ARI ET, BERNSTEIN LR et al. (1995) c-Jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor-promoter-induced transformation. Mol. Carcinogenesis 13, 27.
67. WEBB P, LOPEZ GN, UHT RM, KUSHNER PJ. (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9, 443.
68. WEISZ A, ROSALES R. (1990) Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 18, 5097.
69. YANG-YEN HF, CHAMBARD JC, SUN YL et al. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205.
70. YANG-YEN HF, ZHANG XK, GRAUPNER G et al. (1991) Antagonism between retinoic acid reporters and AP-1: implication for tumor promotion and inflammation. New Biol. 3, 1216.
71. KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17, 407.
72. ZHU X, OHTSUBO M, BOHMER RM, ROBERTS JM, ASSOIAN RK. (1996) Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133, 391.
73. ZINDY F, LAMAS E, CHENIVESSE X et al. (1992) Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182, 1144.